EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Trimethylamine N-Oxide in Heart Failure

Lele Jing, Honghong Zhang, Qiannan Xiang, Huilin Hu, Changlin Zhai, Suining Xu, Hongen Tian

Reviews in Cardiovascular Medicine · 02.07.2024 · 25 (7)

DOI: 10.31083/j.rcm2507240 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 02.07.2024. Verfasst von Lele Jing und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China under Grant, Pioneer innovation team of Jiaxing Institute of atherosclerotic diseases, The Key Medicine Disciplines Co-construction Project of Jiaxing Municipal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the heart. HF is often the final stage of all cardiovascular diseases and a significant risk factor for sudden cardiac arrest, death, and liver or kidney failure. Current pharmacological treatments can only slow the progression and recurrence of HF. With advancing research into the gut microbiome and its metabolites, one such trimethylamine N-oxide (TMAO)—has been implicated in the advancement of HF and is correlated with poor prognosis in patients with HF. However, the precise role of TMAO in HF has not yet been clarified. This review highlights and concludes the available evidence and potential mechanisms associated with HF, with the hope of contributing new insights into the diagnosis and prevention of HF.

Schlagwörter

Stichwörter der Autor:innen

TMAOfecal microbiota transplantation (FMT)gut microbiotaheart failureinflammatory responsemitochondrial dysfunction

Autor:innen und Institutionen

  • Affiliated Hospital of Jiaxing University: First Hospital of Jiaxing, 314000 Jiaxing, Zhejiang, China.
  • Department of Cardiology, The First Affiliated Hospital, Xi'an Jiaotong University, 710061 Xi'an, Shaanxi, China.

Förderung

  • Zhejiang Provincial Natural Science Foundation of China under Grant
  • Pioneer innovation team of Jiaxing Institute of atherosclerotic diseases
  • The Key Medicine Disciplines Co-construction Project of Jiaxing Municipal
  • Program of the First Hospital of Jiaxing
  • Jiaxing Key Laboratory of arteriosclerotic diseases
  • Science and Technology Program of Jiaxing

Zitieren

APA

Jing, L., Zhang, H., Xiang, Q., Hu, H., Zhai, C., Xu, S., & Tian, H. (2024). Role of Trimethylamine N-Oxide in Heart Failure. Reviews in Cardiovascular Medicine, 25(7). https://doi.org/10.31083/j.rcm2507240

Vancouver

Jing L, Zhang H, Xiang Q, Hu H, Zhai C, Xu S, et al. Role of Trimethylamine N-Oxide in Heart Failure. Reviews in Cardiovascular Medicine. 2024;25(7). doi:10.31083/j.rcm2507240

BibTeX
@article{Jing2024,
  author = {Jing, Lele and Zhang, Honghong and Xiang, Qiannan and Hu, Huilin and Zhai, Changlin and Xu, Suining and Tian, Hongen},
  title = {Role of Trimethylamine N-Oxide in Heart Failure},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2024},
  volume = {25},
  number = {7},
  doi = {10.31083/j.rcm2507240}
}
Kostenlos starten →